ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMRS Amyris Inc

0.05
0.00 (0.00%)
27 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Amyris Inc NASDAQ:AMRS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.05 0.053 0.054 0 00:00:00

Form 8-K - Current report

15/08/2023 9:39pm

Edgar (US Regulatory)


8-K0001365916FALSE00013659162023-08-142023-08-14

 
 
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
   
 
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
____________________

Date of report (Date of earliest event reported): August 14, 2023
 
Amyris, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware001-3488555-0856151
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
 
5885 Hollis Street, Suite 100, Emeryville, CA94608    
(Address of Principal Executive Offices) (Zip Code)
 (510)450-0761 
 (Registrant’s telephone number, including area code)
   
 (Former name or former address, if changed since last report.) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
  Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.0001 par value per shareAMRSThe Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On August 14, 2023, Amyris, Inc. (the “Company”) was notified of Philip Eykerman’s decision to resign from the Company’s Board of Directors (the “Board”), effective immediately. Mr. Eykerman had been serving on the Board since May 2017 as a designee of DSM in connection with the right of DSM to designate directors pursuant to the Amended and Restated DSM Stockholder Agreement, dated as of August 7, 2017, by and between DSM and the Company. DSM’s designation rights terminate at such time as DSM beneficially owns less than 4.5% of the Company’s outstanding common stock. DSM currently owns approximately 4.5% of the Company’s outstanding common stock on a beneficial ownership basis. Mr. Eykerman’s resignation is not the result of any disagreement with the Company or due to any matter relating to its operations, policies or practices.







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
  AMYRIS, INC. 
    
    
Date: August 15, 2023By:
 /s/ Han Kieftenbeld
 
  
Han Kieftenbeld
 
Interim Chief Executive Officer and Chief Financial Officer


v3.23.2
Cover
Aug. 14, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 14, 2023
Entity Registrant Name Amyris, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-34885
Entity Tax Identification Number 55-0856151
Entity Address, Address Line One 5885 Hollis Street, Suite 100,
Entity Address, City or Town Emeryville,
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94608
City Area Code (510)
Local Phone Number 450-0761
Entity Central Index Key 0001365916
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol AMRS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Document Information [Line Items]  
Entity Central Index Key 0001365916
Amendment Flag false
Document Type 8-K

1 Year Amyris Chart

1 Year Amyris Chart

1 Month Amyris Chart

1 Month Amyris Chart

Your Recent History

Delayed Upgrade Clock